FDA Recall United States Ongoing2026 recordClass I
A&P CREATIONS
- Product
- X10 Natural Enhancement Supplement, 0.5 fl oz/sachet (15 mL)…
- Published
- October 14, 2026
- Distribution
- Nationwide
A&P CREATIONS Recall: Product contains undeclared Sildenafil and Tadalafil.
United States
OngoingClass I
- Company
- A&P CREATIONS
- Product
- biQ-FEL, 16.9 fl oz (500 mL), 17 servings per bottle, Manufa…
- Recall date
- September 14, 2026
- Source
- FDA
Reason for recall
Product contains undeclared Sildenafil and Tadalafil.
- - Recall initiated
- - Reported by source
| Product description | UPC | Quantity | Lot / code information |
|---|---|---|---|
| biQ-FEL, 16.9 fl oz (500 mL), 17 servings per bottle, Manufactured by ALMENAT SAS AV 39 OESTE No 10 OESTE-18 CALI VALLE INDUSTRIA COLOMBIANA; Distributed by: Biofel | Not published in this source record | 3,116 bottles | Lot # biQ-f001-06-25, Expiry: 05/06/2027; Lot # biQ-003-01-26, Expiry: 01/01/28 |
Distribution
- Distributed nationwide (US).
Official source record
- Agency
- FDA
- Dataset
- FDA Food Enforcement (Recalls)
- Recall number
- H-0017-2027
- Event ID
- 99872
- Status
- Ongoing
- Classification
- Class I
- Company
- A&P CREATIONS
- Product description
- biQ-FEL, 16.9 fl oz (500 mL), 17 servings per bottle, Manufactured by ALMENAT SAS AV 39 OESTE No 10 OESTE-18 CALI VALLE INDUSTRIA COLOMBIANA; Distributed by: Biofel
- Quantity
- 3,116 bottles
- Reason
- Product contains undeclared Sildenafil and Tadalafil.
- Recall initiation date
- September 14, 2026
- Report date
- October 14, 2026
- Classification date
- Not published in this source record
- Termination date
- Not terminated as of this source record
- Distribution pattern
- Distributed nationwide (US).
- UPC, lot, and code information
- Lot # biQ-f001-06-25, Expiry: 05/06/2027; Lot # biQ-003-01-26, Expiry: 01/01/28
- Voluntary or mandated
- Voluntary: Firm initiated
- Initial notification method
- Press Release
- Source last updated
- Not tracked separately from the Public Health Trace retrieval date below
- Public Health Trace retrieval date
Other products recalled under this same event
This recall shares FDA event ID 99872 with 1 other product entry in Public Health Trace.
Responsible company: A&P CREATIONS
Other recalls from A&P CREATIONS
FDA Recall United States Ongoing2026 recordClass I
A&P CREATIONS
- Product
- X10 Natural Enhancement Supplement, 0.5 fl oz/sachet (15 mL)…
- Published
- October 14, 2026
- Distribution
- Nationwide
Where this information comes from
View FDA enforcement record -- the specific openFDA record this summary was built from.
This record comes from FDA's Enforcement Report database. Not every Enforcement Report record has a separate FDA.gov recall-announcement page.
FDA Enforcement Reports -- FDA's general, official recall and enforcement information.
Technical source data
View raw source data -- the machine-readable record this page's information was built from.
Retrieved by Public Health Trace:
Frequently asked questions
What does a Class I mean?
A situation in which there is a reasonable probability that use of or exposure to a product will cause serious adverse health consequences or death.
Is this recall still active?
According to FDA, this recall's status is "Ongoing." Always confirm the current status using the source links below, since status can change after Public Health Trace last retrieved this record.
What should I do if I have this product?
Follow the instructions published by the responsible agency (see the source links below) -- recall guidance (e.g. dispose of the product, return it for a refund, or check for a specific lot number) varies by recall and is set by that agency, not by Public Health Trace.
Where can I find more official information?
The source links below, published by FDA, are the authoritative record for this recall, including any updates issued after this summary was retrieved.
This summary is based on the official source record referenced above. Public Health Trace does not state that any company or product is unsafe beyond what the official source has published. Read the full medical disclaimer.
